Outcome of Sleeve Gastrectomy Converted to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass
- PMID: 35028871
- PMCID: PMC8866292
- DOI: 10.1007/s11695-021-05866-0
Outcome of Sleeve Gastrectomy Converted to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass
Abstract
Purpose: Sleeve gastrectomy (SG) is the commonest bariatric procedure worldwide but there is also a high conversion rate mainly due to weight regain and gastroesophageal reflux disease (GERD) reported in studies with long-term follow-up. The aim of this study is to highlight benefits and limitations of converting SG patients to Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB).
Setting: Retrospective cross-sectional-study, medical university clinic setting.
Methods: This study includes all patients converted from primary SG to RYGB or OAGB by 12/2018 at the Medical University of Vienna. Patients were examined using gastroscopy, esophageal manometry, 24-h pH-metry, and questionnaires.
Results: Fifty-eight patients were converted from SG to RYGB (n = 45) or OAGB (n = 13). Total weight loss of patients converted to RYGB and OAGB was 41.5% and 44.8%, respectively, at nadir. Six patients had Barrett's esophagus (BE) after SG. In four out of these six patients, a complete remission of BE after conversion to RYGB was observed; nevertheless, two patients after RYGB and one after OABG newly developed BE. Clinical GERD improved at a higher rate after RYGB than after OAGB. Both revisional procedures improved associated medical problems.
Conclusion: Conversion to RYGB is probably the best option for patients with GERD after SG. OAGB has shown a low potential to cure patients from GERD symptoms after SG. In terms of additional weight loss and remission of associated medical problems, both procedures studied were equal. Surveillance gastroscopies every 5 years after SG revisions are recommended.
Keywords: Conversion; GERD; One-anastomosis gastric bypass; Quality of life; Roux-en-Y gastric bypass; Sleeve gastrectomy; Weight regain.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Comment in
-
Reply to the Letter to the Editor Concerning Outcome of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass.Obes Surg. 2022 Aug;32(8):2793-2794. doi: 10.1007/s11695-022-06116-7. Epub 2022 May 31. Obes Surg. 2022. PMID: 35641713 No abstract available.
-
Letter to the Editor Outcome of Sleeve Gastrectomy Converted to Roux-en-Y Gastric Bypass and One-Anastomosis Gastric Bypass.Obes Surg. 2022 Aug;32(8):2790-2791. doi: 10.1007/s11695-022-06115-8. Epub 2022 Jun 1. Obes Surg. 2022. PMID: 35650377 No abstract available.
References
-
- Garvey WT, Garber AJ, Mechanick JI, et al. American association of clinical endocrinologists and American college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease. Endocr Pract. 2014;20:977–989. doi: 10.4158/EP14280.PS. - DOI - PMC - PubMed
-
- Felsenreich DM, Ladinig LM, Beckerhinn P, Sperker C, Schwameis K, Krebs M, et al.: Update: 10 years of sleeve gastrectomy-the first 103 patients. Obes Surg 2018 - PubMed
-
- Mandeville Y, Van Looveren R, Vancoillie PJ, Verbeke X, Vandendriessche K, Vuylsteke P, et al.: Moderating the enthusiasm of sleeve gastrectomy: up to fifty percent of reflux symptoms after ten years in a consecutive series of one hundred laparoscopic sleeve gastrectomies. Obes Surg 2017 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials